Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
1. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine
2. Self-Assembled Nanogels: From Particles to Scaffolds and Membranes
3. Single and Multiphoton Responsive Nanomaterials for the Investigation of Cancer Microenvironment
4. Graphene as 2D Nano-Theranostic Materials for Cancer
5. Applications of Plasmonic Nanomaterials for Phototriggered Theranostics
6. Bioengineered Ferritin Nanoprobes for Cancer Theranostics
7. The Role of Nanoscience in Cancer Diagnosis
8. Nanotheranostics and Their Potential in the Management of Metastatic Cancer
9. Targeted Nanotheranostics for Selective Drug Delivery in Cancer
10. Considerations for the Human Health Implications of Nanotheranostics
11. Nanomaterials for Theranostics of Gastric Cancer
12. Nanomaterial Based Photo-Triggered Drug Delivery Strategies for Cancer Theranostics
13. Bio-Nano Interactions
14. Inorganic Nanotheranostic Platforms for Rapid and Reliable Molecular Profiling of Diseases
15. Hydrogels as a New Platform to Recapitulate the Tumor Microenvironment
16. Lipid-Based Nanosystems for the Delivery of siRNA: Challenges and Trends
17. Multiparametric Preclinical Assessment of Theranostics Materials
18. RNAi Nanomaterials and Nanovehicles: Inorganic Nanoparticles for RNAi
19. Theranostic Magnetic Nanoparticles as Molecular Imaging Agents for siRNA Delivery
Handbook of Nanomaterials for Cancer Theranostics focuses on recent developments in advanced theranostic nanomedicines from a chemical and biological perspective where the advantages of theranostics are achieved by combining multiple components. The authors explore the pros and cons of theranostic nanomaterials developed in cancer research in the last 15 years, with the different strategies compared and scrutinized. In addition, the book explores how nanomaterials may overcome the regulatory hurdles facing theranostic nanomedicines.
This is an important research reference for postgraduates and researchers in nanomedicine and cancer research who want to learn more on how nanomaterials can help create more effective cancer treatments.
- Highlights the development of smart theranostic nanomaterials to tackle biomedical problems in cancer therapy and diagnostics
- Explores the regulatory hurdles facing theranostic nanomedicine
- Discusses how the use of nanomaterials can help create more effective cancer treatments
Postgraduates and researchers in the area of nanoscience, biomaterials, nanomedicine, cancer research and drug delivery
- No. of pages:
- © Elsevier 2018
- 19th June 2018
- Paperback ISBN:
- eBook ISBN:
Joao Conde is an independent researcher formally at the Massachusetts Institute of Technology, USA, and Queen Mary University, London, UK. His research interests include (i) biofunctionalization of multifunctional metal nanoparticles with DNA/RNA, siRNA, drugs, dendrimers, fluorescent dyes, polymers, proteins/peptides and antibodies for (ii) cancer therapy and (iii) diagnostics; (iv) in vitro and in vivo applications of new nanomaterials and (v) nanoparticles toxicity/biocompatibility studies. He has published 50 articles in peer-reviewed articles and sits on the Editor Board of two journals.
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.